The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
Open accessAbstract
BACKGROUND: Episodic inflammation in the CNS during the early stages of MS results in progressive disability years later, presumably due to myelin and axonal injury. MRI demonstrates ongoing disease activity during the early disease stage, even in some patients who are stable clinically. The optimal MRI measure for the destructive pathologic process is uncertain, however. METHODS: In this post-hoc study, MRI scans were analyzed from patients with relapsing MS participating in a placebo-controlled trial of interferon beta-1a. The brain parenchymal fraction, defined as the ratio of brain parenchymal volume to the total volume within the brain surface contour, was used to measure whole brain atrophy. The relationship between disease features and brain atrophy and effect of interferon beta-1a were determined. RESULTS: MS patients had significant brain atrophy that worsened during each of 2 years of observation. In many patients, brain atrophy worsened without clinical disease activity. Baseline clinical and MRI abnormalities were not strongly related to the rate of brain atrophy during the subsequent 2 years. Treatment with interferon beta-1a resulted in a reduction in brain atrophy progression during the second year of the clinical trial. CONCLUSIONS: Patients with relapsing-remitting MS have measurable amounts of whole brain atrophy that worsens yearly, in most cases without clinical manifestations. The brain parenchymal fraction is a marker for destructive pathologic processes ongoing in relapsing MS patients, and appears useful in demonstrating treatment effects in controlled clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Self-citationIntramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Granger, C. V., Simon, J. H., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390304 · Cited by 2,450
Self-citationThe IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.655 · Cited by 2,085
Self-citationEbers, G. C. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03334-0 · Cited by 2,073
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,967
Self-citationLosseff, N. A., Webb, S. L., O'Riordan, J. I., Page, R., Wang, L., Barker, G. J., Tofts, P. S., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.3.701 · Cited by 643
Progressive cerebral atrophy in multiple sclerosis A serial MRI study
Losseff, N. A., Wang, L., Lai, H. M., Yoo, D. S., Gawne-Cain, M. L., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.6.2009 · Cited by 479
McFarland, H. F., Frank, J. A., Albert, P. S., Smith, M. E., Martin, R., Harris, J. O., Patronas, N., Maloni, H., & McFarlin, D. E. (1992) · Annals of Neurology · doi:10.1002/ana.410320609 · Cited by 346
A longitudinal study of brain atrophy in relapsing multiple sclerosis
Simon, J. H., Jacobs, L. D., Campion, M. K., Rudick, R. A., Cookfair, D. L., Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., et al. (1999) · Neurology · doi:10.1212/wnl.53.1.139 · Cited by 340
Self-citationMagnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis
Simon, J. H., Jacobs, L. D., Campion, M., Wende, K., Simonian, N., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Richert, J. R., Salazar, A. M., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410430114 · Cited by 330
Self-citationFilippi, M., Horsfield, M. A., Morrissey, S. P., MacManus, D. G., Rudge, P., McDonald, W. I., & Miller, D. H. (1994) · Neurology · doi:10.1212/wnl.44.4.635 · Cited by 314
Arnold, D. L., Riess, G. T., Matthews, P. M., Francis, G. S., Collins, D. L., Wolfson, C., & Antel, J. P. (1994) · Annals of Neurology · doi:10.1002/ana.410360115 · Cited by 192
Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability
Trapp, B. D., Ransohoff, R. M., Fisher, E., & Rudick, R. A. (1999) · The Neuroscientist · doi:10.1177/107385849900500107 · Cited by 190
Self-citationThe role of oligodendroglia and astroglia in wallerian degeneration of the optic nerve
Cook, R. D., & Wis´niewski, H. M. (1973) · Brain Research · doi:10.1016/0006-8993(73)90527-1 · Cited by 159
Jacobs, L., Cookfair, D. L., Rudick, R., Herndon, R. M., Richert, J. R., Salazar, A., Fischer, J., Goodkin, D., Granger, C. V., Simon, J., et al. (1995) · Multiple Sclerosis Journal · doi:10.1177/135245859500100210 · Cited by 122
Self-citationQuantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging.
Simon, J. H., Schiffer, R. B., Rudick, R. A., & Herndon, R. M. (1987) · PubMed · Cited by 73
Self-citationMcFarland, H., Stone, L. A., Calabresi, P. A., Maloni, H. W., Bash, C., & Frank, J. (1996) · Multiple Sclerosis Journal · doi:10.1177/135245859600200406 · Cited by 61
Catch-Up Growth in Short-at-Birth NICU Graduates
Seminara, S., Rapisardi, G., Cauza, F. L., Mattei, P., & Donzelli, G. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023552 · Cited by 58
Simon, J. H. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070106 · Cited by 41
Self-citation
Cited by
Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis
Smith, S. M., Zhang, Y., Jenkinson, M., Chen, J., Matthews, P. M., Federico, A., & De Stefano, N. (2002) · NeuroImage · doi:10.1006/nimg.2002.1040 · Cited by 2,013
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Jacobs, L. D., Beck, R. W., Simon, J. H., Kinkel, R. P., Brownscheidle, C. M., Murray, T. J., Simonian, N. A., Slasor, P. J., & Sandrock, A. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431301 · Cited by 1,501
Self-citationPeterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
Metadata
- Authors
- Rudick, R. A., Fisher, E., Lee, J.-C., Simon, J., Jacobs, L., & the Multiple Sclerosis Collaborative Research Group
- Venue
- Neurology
- Published
- 1999-11
- Volume
- 53
- Issue
- 8
- Pages
- 1698-1698
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2132228594
- Cited by
- 736
- References
- 20
- FWCI
- 24.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.